Cargando…
Surfactin Mitigates a High-Fat Diet and Streptozotocin-Induced Type 2 Diabetes through Improving Pancreatic Dysfunction and Inhibiting Inflammatory Response
Surfactin from Bacillus amyloliquefaciens fmb50 was utilized to treat mice with type 2 diabetes (T2DM) induced by a high-fat diet/streptozotocin (HFD/STZ). Our group’s earlier research indicated that surfactin could lower blood glucose and mitigate liver dysfunction to further improve HFD/STZ-induce...
Autores principales: | Chen, Xiaoyu, Zhao, Hongyuan, Lu, Yajun, Liu, Huawei, Meng, Fanqiang, Lu, Zhaoxin, Lu, Yingjian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570334/ https://www.ncbi.nlm.nih.gov/pubmed/36232419 http://dx.doi.org/10.3390/ijms231911086 |
Ejemplares similares
-
Ameliorated effects of a lipopeptide surfactin on insulin resistance in vitro and in vivo
por: Chen, Xiaoyu, et al.
Publicado: (2022) -
Enhanced Expression of Pullulanase in Bacillus subtilis by New Strong Promoters Mined From Transcriptome Data, Both Alone and in Combination
por: Meng, Fanqiang, et al.
Publicado: (2018) -
The protective effect of sulforaphane on type II diabetes induced by high‐fat diet and low‐dosage streptozotocin
por: Tian, Shuhua, et al.
Publicado: (2020) -
Differential Proteomics Analysis of Bacillus amyloliquefaciens and Its Genome-Shuffled Mutant for Improving Surfactin Production
por: Zhao, Junfeng, et al.
Publicado: (2014) -
Identification of novel surfactin derivatives from NRPS modification of Bacillus subtilis and its antifungal activity againstFusarium moniliforme
por: Jiang, Jian, et al.
Publicado: (2016)